Fractyl Health (GUTS) Invested Capital (2023 - 2026)
Fractyl Health (GUTS) reported Invested Capital of $21.4 million for Q1 2026, up 235.33% year-on-year from $6.4 million in Q1 2025, and up 126.02% quarter-over-quarter from $9.5 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Invested Capital data on file, last reported at $21.4 million in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital rose 235.33% year-over-year to $21.4 million; the trailing twelve-month figure through Mar 2026 stood at $21.4 million (up 235.33% YoY), and the FY2025 full-year result was $9.5 million, down 66.73% from the prior year.
- Invested Capital for Q1 2026 stood at $21.4 million, up from $9.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $84.2 million in Q1 2024 and bottomed at -$325.1 million in Q4 2023.
- A 4-year average of -$72.2 million and a median of $6.4 million in 2025 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital plunged 125.74% in 2025 and surged 235.33% in 2026, its largest moves.
- Tracing GUTS's Invested Capital over 4 years: stood at -$325.1 million in 2023, then soared by 108.74% to $28.4 million in 2024, then sank by 66.73% to $9.5 million in 2025, then soared by 126.02% to $21.4 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $21.4 million, $9.5 million, and -$3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 21.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.38 Mn |
| Dec 31, 2025 | 9.46 Mn |
| Sep 30, 2025 | -3.18 Mn |
| Jun 30, 2025 | -18.21 Mn |
| Mar 31, 2025 | 6.38 Mn |
| Dec 31, 2024 | 28.42 Mn |
| Sep 30, 2024 | 50.32 Mn |
| Jun 30, 2024 | 70.76 Mn |
| Mar 31, 2024 | 84.18 Mn |
| Dec 31, 2023 | -325.06 Mn |
| Sep 30, 2023 | -307.18 Mn |
| Jun 30, 2023 | -292.52 Mn |
| Mar 31, 2023 | -263.39 Mn |